Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 6/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.35 |
| ▸ | HTR2B | P41595 | 1/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24499214 | 0.86 | — | — | |
| SCHEMBL12122255 | 0.82 | — | — | |
| SCHEMBL20133058 | 0.80 | — | — | |
| SCHEMBL22644586 | 0.76 | — | — | |
| SCHEMBL18650007 | 0.76 | FABP3 (0.30) | FABP3FABP4 | |
| SCHEMBL20133057 | 0.74 | KDM5A (0.40) | — | |
| SCHEMBL1126813 | 0.74 | NOTUM (0.52) | CYP1A2HPGDTSHRFABP3FABP4 | |
| SCHEMBL2990926 | 0.73 | HCAR2 (0.31) | — | |
| SCHEMBL16921537 | 0.72 | GABRA1 (0.37) | GABRA1GABRB1GABRB2CA1CA2 | |
| SCHEMBL1156156 | 0.69 | NR4A2 (0.40) | CA1CA2LMNATSHRGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8362278-B2 | Methods for the conversion of a substituted furan to a substituted pyrrole | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2013-01-29 | — | — | US | claimed |
| US-20120083609-A1 | METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-04-05 | — | — | US | claimed |
| CN-122070352-A | Sustainable aviation fuel produced from normal alpha olefin byproducts and method thereof | 切弗朗菲利浦化学公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12618016-B2 | Methods for producing aviation fuels | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-05-05 | — | — | US | disclosed |
| US-20260103649-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2026-04-16 | — | — | US | disclosed |
| WO-2026043730-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-26 | — | — | WO | disclosed |
| US-20260049256-A1 | METHODS FOR PRODUCING AVIATION FUELS | CHEVRON PHILLIPS CHEMICAL COMPANY LP | 2026-02-19 | — | — | US | disclosed |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-02-03 | — | — | US | disclosed |
| US-12528999-B2 | Sustainable jet fuel and process | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-01-20 | — | — | US | disclosed |
| WO-2025054252-A1 | SUSTAINABLE JET FUEL AND PROCESS | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-03-13 | — | — | WO | disclosed |
| US-20250084331-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2025-03-13 | — | — | US | disclosed |
| US-7612218-B2 | Process for production of heteroaryl-type boron compounds with iridium catalyst | MITSUBISHI RAYON CO., LTD. (JP) | 2009-11-03 | — | — | US | disclosed |
| US-7572784-B2 | Compounds and methods for inhibiting mitotic progression | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2009-08-11 | — | — | US | disclosed |
| EP-1771450-B9 | COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION BY INHIBITION OF AURORA KINASE | MILLENNIUM PHARM INC (US) | 2008-12-24 | — | — | EP | disclosed |
| EP-1905773-A2 | Compounds and methods for inhibiting mitotic progression by inhibition of aurora kinase | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2008-04-02 | — | — | EP | disclosed |
| US-20080045501-A1 | Pyridobenzazepine compounds and methods for inhibiting mitotic progression | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2008-02-21 | — | — | US | disclosed |
| EP-1771450-B1 | COMPOUNDS AND METHODS FOR INHIBITING MITOTIC PROGRESSION BY INHIBITION OF AURORA KINASE | MILLENNIUM PHARM INC (US) | 2007-12-19 | — | — | EP | disclosed |
| US-20070185087-A1 | Compounds and methods for inhibiting mitotic progression | MILLENNIUM PHARMACEUTICALS, INC. (US) | 2007-08-09 | — | — | US | disclosed |
| US-20050148775-A1 | Process for production of heteroaryl-type boron compounds with iridium catalyst | MITSUBISHI RAYON CO., LTD. (JP) | 2005-07-07 | — | — | US | disclosed |
| EP-1481978-A1 | PROCESS FOR PRODUCTION OF HETEROARYL-TYPE BORON COMPOUNDS WITH IRIDIUM CATALYST | Mitsubishi Rayon Co., Ltd. (JP) | 2004-12-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12618016-B2 | Methods for producing aviation fuels | CYP4F8, CYP8B1, CYP2E1 | GABRA1 3274/4885GABRB1 2416/4885GABRB2 2625/4885 |
| US-20120083609-A1 | METHODS FOR THE CONVERSION OF A SUBSTITUTED FURAN TO A SUBSTITUTED PYRROLE | PAH, CPS1, ASNS | GABRA1 3232/4885GABRB1 3015/4885GABRB2 2608/4885 |
| US-20250084331-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | ECH1, YAP1, ECHS1 | GABRA1 3236/4885GABRB1 3402/4885GABRB2 3388/4885 |
| US-20260103649-A1 | SUSTAINABLE AVIATION FUEL FROM NORMAL ALPHA OLEFIN BYPRODUCTS AND PROCESS FOR SAME | YAP1, CYP4F8, SCD | GABRA1 968/4885GABRB1 1045/4885GABRB2 1064/4885 |
| US-20070185087-A1 | Compounds and methods for inhibiting mitotic progression | AURKC, AURKA, AURKB | GABRA1 4822/4885GABRB1 4811/4885GABRB2 4817/4885 |
| US-20050148775-A1 | Process for production of heteroaryl-type boron compounds with iridium catalyst | PIN4, IPO5, HLCS | GABRA1 691/4885GABRB1 792/4885GABRB2 985/4885 |
| US-12528999-B2 | Sustainable jet fuel and process | CYP2E1, ADH1C, PCCA | GABRA1 841/4885GABRB1 789/4885GABRB2 743/4885 |
| US-20260049256-A1 | METHODS FOR PRODUCING AVIATION FUELS | CYP4F8, CPT1A, CBR1 | GABRA1 3112/4885GABRB1 2556/4885GABRB2 2845/4885 |
| US-12540287-B2 | Sustainable aviation fuel from normal alpha olefin byproducts and process for same | ADH1A, ADH1C, YAP1 | GABRA1 1162/4885GABRB1 1020/4885GABRB2 1127/4885 |
| US-20080045501-A1 | Pyridobenzazepine compounds and methods for inhibiting mitotic progression | AURKB, AURKC, AURKA | GABRA1 4405/4885GABRB1 3978/4885GABRB2 3946/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.